Quantx Biosciences, Inc.
Clinical trials sponsored by Quantx Biosciences, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- First human trial of QX-4533 begins safety testing Results expected Dec 2026 (estimated)
- Can a pill tame severe eczema? a new trial puts QX-4533 to the test Results expected Apr 2027 (estimated)
-
Can a pill tame severe eczema? a new trial puts QX-4533 to the test
Disease control Recruiting nowThis early-stage trial tests an oral drug called QX-4533 in healthy volunteers and in people with moderate-to-severe atopic dermatitis, a common type of eczema. The main goal is to check the drug's safety and how the body processes it, while also looking for early signs that it m…
Phase 1 • Sponsor: QuantX Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
First human trial of QX-4533 begins safety testing
Knowledge-focused Recruiting nowThis phase 1 trial tests the safety and tolerability of a new drug called QX-4533 in 90 healthy adults aged 18 to 55. Participants receive either single or multiple doses of the drug or a placebo, and the study also looks at how food affects the drug's levels in the body. The goa…
Phase 1 • Sponsor: QuantX Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC